161 related articles for article (PubMed ID: 10421074)
1. Systemic chemotherapy with vincristine, cyclophosphamide, doxorubicin and prednisolone following radiotherapy for primary central nervous system lymphoma: a phase II study.
Shibamoto Y; Sasai K; Oya N; Hiraoka M
J Neurooncol; 1999 Apr; 42(2):161-7. PubMed ID: 10421074
[TBL] [Abstract][Full Text] [Related]
2. Therapy of primary central nervous system lymphoma with pre-irradiation methotrexate, cyclophosphamide, doxorubicin, vincristine, and dexamethasone (MCHOD).
Glass J; Shustik C; Hochberg FH; Cher L; Gruber ML
J Neurooncol; 1996 Dec; 30(3):257-65. PubMed ID: 8943101
[TBL] [Abstract][Full Text] [Related]
3. Primary central nervous system lymphoma in Japan: a nationwide survey.
Hayabuchi N; Shibamoto Y; Onizuka Y
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):265-72. PubMed ID: 10760418
[TBL] [Abstract][Full Text] [Related]
4. Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy.
Shibamoto Y; Tsutsui K; Dodo Y; Yamabe H; Shima N; Abe M
Cancer; 1990 May; 65(9):1907-12. PubMed ID: 2372761
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of primary central nervous system lymphoma: the role of chemotherapy].
Maeda Y; Matsumoto K; Kuriyama M; Ono Y; Kunishio K; Tamiya T; Furuta T; Ohmoto T
Gan To Kagaku Ryoho; 1997 May; 24(7):807-13. PubMed ID: 9170518
[TBL] [Abstract][Full Text] [Related]
6. Reduced neurotoxicity with combined treatment of high-dose methotrexate, cyclophosphamide, doxorubicin, vincristine and prednisolone (M-CHOP) and deferred radiotherapy for primary central nervous system lymphoma.
Ichikawa T; Kurozumi K; Michiue H; Ishida J; Maeda Y; Kondo E; Kawasaki A; Date I
Clin Neurol Neurosurg; 2014 Dec; 127():106-11. PubMed ID: 25459253
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
8. Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
Arellano-Rodrigo E; López-Guillermo A; Bessell EM; Nomdedeu B; Montserrat E; Graus F
Eur J Haematol; 2003 Apr; 70(4):219-24. PubMed ID: 12656744
[TBL] [Abstract][Full Text] [Related]
9. Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma (PCL).
Brada M; Hjiyiannakis D; Hines F; Traish D; Ashley S
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1157-62. PubMed ID: 9539572
[TBL] [Abstract][Full Text] [Related]
10. Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?
O'Neill BP; O'Fallon JR; Earle JD; Colgan JP; Brown LD; Krigel RL
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):663-73. PubMed ID: 7558957
[TBL] [Abstract][Full Text] [Related]
11. A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy.
Mead GM; Bleehen NM; Gregor A; Bullimore J; Shirley D; Rampling RP; Trevor J; Glaser MG; Lantos P; Ironside JW; Moss TH; Brada M; Whaley JB; Stenning SP
Cancer; 2000 Sep; 89(6):1359-70. PubMed ID: 11002232
[TBL] [Abstract][Full Text] [Related]
12. Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: a secondary analysis of RTOG studies 83-15 and 88-06.
Corn BW; Dolinskas C; Scott C; Donahue B; Schultz C; Nelson DF; Fisher B
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):299-303. PubMed ID: 10802352
[TBL] [Abstract][Full Text] [Related]
13. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.
Schultz C; Scott C; Sherman W; Donahue B; Fields J; Murray K; Fisher B; Abrams R; Meis-Kindblom J
J Clin Oncol; 1996 Feb; 14(2):556-64. PubMed ID: 8636771
[TBL] [Abstract][Full Text] [Related]
14. Major prognostic factors of adult patients with advanced B-cell lymphoma treated with vincristine, cyclophosphamide, prednisone and doxorubicin (VEPA) or VEPA plus methotrexate (VEPA-M).
Shimoyama M; Ota K; Kikuchi M; Yunoki K; Konda S; Takatsuki K; Ogawa M; Tominaga S; Tsugane S; Minato K
Jpn J Clin Oncol; 1988 Jun; 18(2):113-24. PubMed ID: 3379782
[TBL] [Abstract][Full Text] [Related]
15. Primary cerebral lymphoma: an argument for the use of adjunctive systemic chemotherapy.
Rosenthal MA; Sheridan WP; Green MD; Liew K; Fox RM
Aust N Z J Surg; 1993 Jan; 63(1):30-2. PubMed ID: 8466457
[TBL] [Abstract][Full Text] [Related]
16. Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.
Wu HG; Kim IH; Ha SW; Park CI; Bang YJ; Huh DS
J Korean Med Sci; 1999 Oct; 14(5):565-70. PubMed ID: 10576154
[TBL] [Abstract][Full Text] [Related]
17. Central nervous system lymphomas: progress in chemotherapy and radiotherapy.
Brada M
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):769-71. PubMed ID: 7558971
[No Abstract] [Full Text] [Related]
18. [Combination chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (VEPA) for non-Hodgkin's lymphoma].
Saaki A; Yokomatsu Y; Kojima K; Yoshikawa T; Sannomiya Y; Tatsumi J; Hashimoto K; Park K; Kawarabayashi K; Yoshikawa C
Gan To Kagaku Ryoho; 1986 Jan; 13(1):65-9. PubMed ID: 3753642
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Ghesquières H; Ferlay C; Sebban C; Perol D; Bosly A; Casasnovas O; Reman O; Coiffier B; Tilly H; Morel P; Van den Neste E; Colin P; Haioun C; Biron P; Blay JY
Ann Oncol; 2010 Apr; 21(4):842-850. PubMed ID: 19914958
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group.
Kobayashi T; Tobinai K; Shimoyama M; Mikuni C; Konda S; Kozuru M; Araki K; Sai T; Fukuhara S; Matsumoto M; Aoki I; Deura K; Oyama A; Hotta T; Abe T; Toki H; Nagai M; Fukuda H; Niimi M; Yamaguchi N; Tajima K; Shirakawa S
Jpn J Clin Oncol; 1999 Jul; 29(7):340-8. PubMed ID: 10470659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
